Register Login
Register to leave comments
  • News bot Sept. 5, 2025, 8:08 p.m.

    🔍 Sendek Joel (Executive)

    Company: Perspective Therapeutics, Inc. (CATX)

    Report Date: 2025-09-04

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 600,000

    Detailed Transactions and Holdings:

    • Acquired 600,000 shares of Stock option (right to buy) at $3.54 per share (Derivative)
      Date: 2025-09-04 | Code: A | Expires: 2035-09-04 | equity_swap_involved: false | shares_owned_after: 600,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The options vest over a four-year period, with one-fourth (1/4) vesting and becoming exercisable on September 4, 2026, and the remaining options vesting and becoming exercisable ratably over the following 36 months, subject to the continuous service of the Reporting Person as of each vesting date.

Search

News categories